RxDoctor Payments Data

Scott Price, DPM

Podiatrist · Prescott Valley, AZNPI 1417067455

Payments from drug & device makers

$841in general payments, 2019–2025

Across 39 payments — averaging $21.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Next Science LLC$142
  • Organogenesis Inc.$93
  • Aap Implants Inc$79
  • Paratek Pharmaceuticals, Inc.$72
  • Merck$64
  • Smith+Nephew$48
  • plus $343 from 13 others

What the payments were for

  • Food & beverage$841100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Next Science LLC5$142
Organogenesis Inc.4$93
Aap Implants Inc2$79
Paratek Pharmaceuticals, Inc.4$72
Merck4$64
Smith+Nephew2$48
Averitas Pharma Inc.1$42
Mimedx Group, Inc.2$39
Orthofix Medical, Inc.3$38
Surgenex LLC1$32
Avanos Medical1$28
Tactile Systems Technology Inc2$26
Alfasigma USA, Inc.1$23
Kerecis Limited1$22
Melinta Therapeutics, LLC2$22
Biowound Solutions, Inc.1$20
Bioventus LLC1$20
DJO, LLC1$15
Abbott1$15

How this compares

$841 in reported general payments places this provider in the 55th percentile of 151 podiatrist providers in Arizona.

See all podiatrist providers in Arizona

Medicare billing

Part B allowed, 2024
$313,819
Medicare patients
969
Services billed
4,496

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib102$2,054
Pregabalin29$663
Terbinafine Hcl61$657
Doxycycline Hyclate37$428
Gabapentin13$349
Mupirocin31$193
Methylprednisolone32$149
Allopurinol18$149

Paid to pharmacies, not to this prescriber.

Other podiatrist in Prescott Valley

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →